| Literature DB >> 36053281 |
Maha A Fahmy1, Ayman A Farghaly1, Entesar E Hassan1, Zeinab M Hassan2, Howaida I Abd-Alla3.
Abstract
BACKGROUND: Carmustine (Cr) is an important chemotherapeutic drug, widely used in the treatment of brain tumors. Herein, the protective role of Codiaeum variegatum leaves ethyl acetate fraction was determined against genotoxicity of Cr. The technique HPLC-qTOF-MS/MS was used to identify the constituents in C. variegatum. MATERIALS: 90 male mice were used to evaluate micronuclei (MPCEs) in bone marrow, chromosomal aberration (CAs) in bone marrow and mouse spermatocytes, sperm abnormalities, and gene expression (qRT-PCR). The following groups were included, I: Negative control (ethanol 30%), II: Positive control (i.p injected once with 30 mg/kg Cr), III: Control orally treated with C. variegatum at 500 mg/kg, four days. IV-VI: treated with 100, 300, and 500 mg/kg of the plant (4 days) plus a single dose of Cr.Entities:
Keywords: C-glycosyl flavones; Carmustine; Codiaeum variegatum; Gene expression; Genotoxicity; HPLC-qTOF-MS/MS; Protective role
Mesh:
Substances:
Year: 2022 PMID: 36053281 PMCID: PMC9515021 DOI: 10.1007/s11033-022-07845-9
Source DB: PubMed Journal: Mol Biol Rep ISSN: 0301-4851 Impact factor: 2.742
Primers sequence used for qRT-PCR
| Gene | Primers sequence | NCBI Reference |
|---|---|---|
| p53 | F: ACA GTC GGA TAT CAG CCT CG | AB021961.1 |
| R: GCT TCA CTT GGG CCT TCA AA | ||
| GAPDH | F:GGA TGC AGG GAT GAT GTT CT | NM_017008.3 |
| R:GAA GGG CTC ATT GAC CAC AGTT |
GAPDH: glyceraldehyde-3-phosphate dehydrogenase,
P53: tumor protein p53 gene
Percentage of polychromatic erythrocytes (PCEs) and PCEs with micronuclei (MPCEs); chromosomal aberrations induced in mouse bone marrow cells after treatment with carmustine and Codiaeum variegatum
| Treatment and doses | No. and percentage of PCEs/(PCEs + NCPs) | No. and percentage of MPCEs | Total abnormal metaphases | No and (%) of metaphases with different types of chromosome aberrations | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| NO | Mean ± S.E | NO | Mean ± S.E | No | Mean (%) ± SE | Gap | Fragment and/or break | Multiple aberrations | R.T | |
| I. Control (30% ethanol) | 419 | 4.19 ± 0.37a | 11 | 2.63 ± 0.63a | 23 | 4.60 ± 0.4 a | 7 (1.40) | 16 (3.20) | – | – |
| II. Carmustine (30 mg / kg) | 1448 | 14.48 ± 0.49d | 143 | 9.88 ± 0.58c | 163 | 32.60 ±0.0.75 e | 12 (2.40) | 42 (8.40) | 102 (20.40) | 7 (1.40) |
| III. | 438 | 4.38 ± 0.54a | 13 | 2.97 ± 0.27a | 16 | 3.20 ± 0.58a | 7 (1.40) | 9 (1.80) | – | – |
| IV-VI- Carmustine + | ||||||||||
| + 100 mg/kg | 1132 | 11.32 ± 0.53c | 88 | 7.77 ± 0.61 c | 130 | 26.0 ± 0.89d | 14 (2.80) | 37 (7.40) | 72 (14.40) | 7 (1.40) |
| + 300 mg/kg | 1005 | 10.05 ± 0.49b | 67 | 6.67 ± 0.49 b | 107 | 21.40 ± 0.98 c | 13 (2.60) | 41 (8.20) | 49 (9.80) | 4 (0.80) |
| + 500 mg/kg | 887 | 8.87 ± 0.32b | 51 | 5.75 ± 0.26 b | 86 | 17.20 ± 0.86b | 11 (2.20) | 35 (7.0) | 36 (7.20) | 4 (0.80) |
A total of 500 cells were analyzed (5 mice per group; 100 cells/mouse) for chromosomal aberrations. R.T.: Robertsonian translocation. No. of examined nucleated cells = 2000/mouse (5 mice/group) for micronuclei test.One way ANOVA–Tukey’s multiple comparisons test was used. The values having different superscript letters in each column are significantly different from one another at p < 0.05
Fig. 1A Chromosomal abnormalities in bone marrow cells in mice showing (a) normal (b) fragment and Robertsonian translocation and (c) breaks. B Chromosomal abnormalities in diakinase- metephase 1 cells in mice showing (a) normal, (b) XY univalent and (c) autosomal univalent. C Sperm abnormalities in mice showing (a) normal, (b) without hook, (c) amorphous, (d) triangular, (e) banana and (f, g) coiled tail
Percentage of chromosomal aberrations in mouse spermatocytes and sperm abnormalities induced after treatment with carmustine and Codiaeum variegatum
| Treatment and doses | Total abnormal metaphases | No. of different types of sperm abnormalities | Total abnormal sperm | |||
|---|---|---|---|---|---|---|
| No | Mean(%) ± SE | Head abnormalities | Tail abnormalities | No | Mean (%) ± SE | |
| I. Control (30% ethanol) | 19 | 3.80 ± 0.37 a | 126 | 86 | 212 | 4.24 ± 0.19a |
| II.Carmustine (30 mg / kg) | 84 | 16.80 ± 0.97c | 274 | 252 | 526 | 10.52 ± 0.21e |
| III. | 16 | 3.20 ± 0.49 a | 122 | 104 | 226 | 4.52 ± 0.38a |
| IV-VI- Carmustine + | ||||||
| + 100 mg/kg | 54 | 10.80 ± 0.97 b | 276 | 201 | 477 | 9.54 ± 0.46d |
| + 300 mg/kg | 46 | 9.20 ± 0.58b | 191 | 191 | 382 | 7.64 ± 0.31c |
| + 500 mg/kg | 43 | 8.60 ± 0.75 b | 156 | 164 | 320 | 6.40 ± 0.24 b |
A total of 500 cells were analyzed for chromosomal aberrations (5 mice per group; 100 cells/mouse). Total number of examined sperms 5000 per each treatment (1000 /mouse, 5 mice/group). One way ANOVA–Tukey’s multiple comparisons test was used. The values having different superscript letters in each column are significantly different from one another at p < 0.05
Fig. 2P53 gene expression as indicated by q RT-PCR in mice liver cells
The gene expression of P53 gene as indicated by RT-PCR
| Treatment | Mean | SEM |
|---|---|---|
| I. Control (30% ethanol) | 1 | 0.02 |
| II.Carmustine (30 mg / kg) | 3.94 | 0.07 |
| III. | 1.28 | 0.03 |
| IV-VI- Carmustine + | ||
| + 100 mg/kg | 3.61 | 0.04 |
| + 300 mg/kg | 2.56 | 0.07 |
| + 500 mg/kg | 1.84 | 0.04 |